Cardiac medical device startup Mardil seeks $12 million to treat mitral valves

Mardil, one of the newest companies based in Minnesota, wants to create a new innovative medical device that treats sloppy mitral valves short of doing open-heart surgery. It is trying to raise up to $12 million.

[Read more of this report]


Dell buy puts medical images in the cloud (Morning Read)

Dell said it will acquire Insite One, a developer of applications that enables doctors to share medical images in the cloud, for an undisclosed price, reports VentureBeat.

[Read more of this report]


Detroit Venture Partners [hearts] Motor City (Morning Read)

Detroit Venture Partners wants its portfolio companies to move their operations to the heart of Detroit in the hopes of transforming the Motor City into a vibrant startup community like Boston and San Francisco, according to Xconomy Detroit.

[Read more of this report]


Dealmaking machine Sanofi to buy Avila for $800M (Morning Read)

The dealmaking machine that is Sanofi-Aventis is at it again, signing an oncology drug pact with Avila Therapeutics in Waltham, Massachusetts, worth $40 million up front and up to $154 million in milestone payments per program. Overall, the deal is valued at $800 million, according to FierceBiotech.

[Read more of this report]


Stanford docs may be too cozy with drug companies (Morning Read)

As medical schools wrestle with how to keep drug companies from corrupting their faculties, Stanford University often is lauded for its tough stance. But a ProPublica investigation found that more than a dozen of the school’s doctors were

[Read more of this report]


Medtronic gives artificial pancreas a brain (Weekend Rounds)

The artificial pancreas just got a brain. Medtronic Inc. (NYSE:MDT) said Monday the Food and Drug Administration has approved software that helps manage a patient’s diabetes therapy.

[Read more of this report]


Women anguish over FDA’s Avastin pull (Morning Read)

The Food and Drug Administration on Thursday moved toward revoking approval of the blockbuster cancer drug Avastin as a treatment for breast cancer, drawing criticism for limiting treatment options for desperately ill women, reports the Chicago Tribune.

[Read more of this report]


Health reform politics play out over generation (Morning Read)

As the history of social legislation suggests — and as this week’s federal court ruling on the so-called individual mandate makes clear, the effects of healthcare reform on our politics may not be settled until a lot of President Obama’s aides are collecting Medicare checks, according to the New York Times.

[Read more of this report]


ObamaCare: Facing down Grinch or Sanity Clause?(Morning Read)

The U.S. Constitution’s Commerce Clause states that Congress has the power to “regulate Commerce ’ among the several States.” To supporters of health reform, the Commerce Clause is the Grinch that stole Obamacare, writes the Health Care Blog. To opponents, it might seem like a Sanity Clause.

[Read more of this report]


Theken Spine wins $200K Ohio grant to unify spinal fusion firms

The Ohio Controlling Board today approved Theken Spine LLC for a $200,000 Rapid Outreach grant to buy new machinery and equipment. The Akron maker of implantable hardware for spinal fusion surgery is consolidating four facilities at a Medina building, which will be renovated and used for offices, warehousing and product manufacturing.

[Read more of this report]


Older Posts »

Be a Thought Leader: Join MedCitizens

Anyone can blog on MedCity News when they become a "MedCitizen." MedCitizens publish their own thoughts about current medical news and the latest issues in healthcare to the entire MedCity News audience.

Click to login or learn more

MedCity Twitter Buzz

MedCity Jobs Board

Real Time Web Analytics